ALLMedicine™ Stevens-Johnson Syndrome Center

Feb 26th, 2021 - Biologic drugs have the potential to halt the progression of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) by decreasing concentrations of tumor necrosis factor-α, a cytokine implicated in epithelial cell death. The objective...

Feb 23rd, 2021 - Effect of older age on complications and mortality of inpatients with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis.|2021|Patel S,Cadwell JB,Lambert WC,|

Feb 22nd, 2021 - Human leukocyte antigen class I and II genes associated with dipyrone-related Stevens-Johnson syndrome and severe ocular complications in a Brazilian population.|2021|Wakamatsu TH,Ueta M,Inoue C,Costa KA,Sakano LY,|

Feb 15th, 2021 - Recurrence of nivolumab-induced Stevens-Johnson syndrome due to tegafur/gimeracil/oteracil (TS-1®) after nivolumab discontinuation.|2021|Komatsu-Fujii T,Ogawa M,Nonoyama S,Fukumoto T,Tanabe H,|

Feb 9th, 2021 - Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN) are Severe Cutaneous Adverse Reactions (SCARS) characterized by fever and mucocutaneous lesions leading to necrosis and sloughing of the epidermis. Conjunctival lesions are report...

Mar 10th, 2020 - Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening conditions with high morbidity and mortality. Supportive care management of SJS/TEN is highly variable. A systematic review of the literature was performed by...

Jun 24th, 2019 - Acute generalized exanthematous pustulosis (AGEP), drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, and Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) are types of adverse drug reactions (ADRs), each with their ...

Mar 4th, 2019 - British Association of Dermatologists' guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in children and young people, 2018.|2019|McPherson T,Exton LS,Biswas S,Creamer D,Dziewulski P,|methods,standards,standards,...

Jun 18th, 2016 - U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016.|2016|Creamer D,Walsh SA,Dziewulski P,Exton LS,Lee HY,|therapeutic use,methods,therapeutic use,therapy,therapy,methods,therapeutic use,therapy...

Aug 7th, 2014 - Phenytoin is a widely used antiepileptic drug with a narrow therapeutic index and large interpatient variability, partly due to genetic variations in the gene encoding cytochrome P450 (CYP)2C9 (CYP2C9). Furthermore, the variant allele HLA-B*15:02,...

Feb 26th, 2021 - Biologic drugs have the potential to halt the progression of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) by decreasing concentrations of tumor necrosis factor-α, a cytokine implicated in epithelial cell death. The objective...

Feb 23rd, 2021 - Effect of older age on complications and mortality of inpatients with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis.|2021|Patel S,Cadwell JB,Lambert WC,|

Feb 22nd, 2021 - Human leukocyte antigen class I and II genes associated with dipyrone-related Stevens-Johnson syndrome and severe ocular complications in a Brazilian population.|2021|Wakamatsu TH,Ueta M,Inoue C,Costa KA,Sakano LY,|

Feb 15th, 2021 - Recurrence of nivolumab-induced Stevens-Johnson syndrome due to tegafur/gimeracil/oteracil (TS-1®) after nivolumab discontinuation.|2021|Komatsu-Fujii T,Ogawa M,Nonoyama S,Fukumoto T,Tanabe H,|

Feb 11th, 2021 - Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, seasonal or perennial allergic rhinitis and serum s...

Sep 10th, 2019 - NEW YORK – Inpatient dermatology consults can make all the difference when a serious dermatology complication is suspected, said Lucia Seminario-Vidal, MD, PhD, speaking at a hospital dermatology–focused session of the summer meeting of the Americ.

Aug 8th, 2019 - The physician thought that this was most likely toxic epidermal necrolysis (TEN). He was in a small hospital without a burn unit, so he drew baseline labs and blood cultures, and started to give intravenous fluids to treat the dehydration.

Apr 11th, 2019 - To the Editor: A 25-year-old woman with no notable medical history was admitted to the hospital for suspected Stevens-Johnson syndrome (SJS). The patient was started on amoxicillin 7 days prior to the skin eruption for prophylaxis before removal o.

Apr 8th, 2019 - Conclusion Although Stevens-Johnson syndrome is a rare cause of onychomadesis, and the pathophysiology of this sequela is poorly understood, this case illustrates a common nail abnormality with multiple potential etiologies that are discerned by a.

Nov 21st, 2018 - Researchers have identified biomarkers that might eventually be used to flag cancer patients with severe cutaneous adverse reactions (SCARs) at an increased risk of mortality. In a retrospective study, elevated elafin, interleukin (IL)-6, and tumo.